Lakewood Exploration: Silver Strand 43-101, Exploration, Adds Two Silver Projects in Nevada
Source: Maurice Jackson for Streetwise Reports��(9/15/21)
Joining us is Morgan Lekstrom, the CEO of Lakewood Exploration, which is on track to become the next pure silver play in the US. In this interview, Mr. Lekstrom discusses the latest update on the pending NI43-101 on the flagship Silver Strand, along with current exploration successes and new additions to the property bank, both in the prolific Hamilton District of Nevada, which are the Eliza Silver Project and Silverton Silver Mine, and we will conclude with pending catalysts. More >

Echoes of the 1970s Haunt Modern Markets
Source: Michael Ballanger for Streetwise Reports��(9/15/21)
Sector expert Michael Ballanger explores how modern financial times mirror his formative years in the 1970s. More >

French Biotech Firm Initiates Pivotal Phase 3 Study of Lanifibranor in 900 NASH Patients
Source: Streetwise Reports��(9/15/21)
ROTH Capital Partners LLC advised in a research report that Inventiva S.A. has initiated enrollment in its highly anticipated pivotal Phase 3 Study of Lanifibranor in individuals diagnosed with nonalcoholic steatohepatitis. ROTH rates Inventiva a "Buy" with a 12-month price target of €55/share which represents a nearly four-fold increase over the current share price. More >

Instil Bio Receives FDA Approval to Initiate Expanded Phase 2 Advanced Melanoma Study
Source: Streetwise Reports��(9/15/21)
Shares of Instil Bio Inc. traded 16% higher after the company reported it received IND clearance from the U.S. FDA to initiate a Phase 2 clinical trial in advanced melanoma patients. More >

'Bona Fide Discovery' in Early Drilling at a Yukon Gold Project
Source: Streetwise Reports��(9/14/21)
In a recent broadcast, Geologic and Technical Director to Crescat Capital, Dr. Quinton Hennigh, provided updates on three exploration companies with recent news and covered seven other exploration stories of note. More >

Biopharma Co. Posts Positive Objective Response & Disease Control Rates in Ovarian Cancer Studies
Source: Streetwise Reports��(9/14/21)
H.C. Wainwright & Co. advised in a research report that updated data from Mersana Therapeutics Inc.'s expansion study supports its UPLIFT Study and will provide the basis for a new Phase 3 study in 2022. H.C. Wainwright rates Mersana a "Buy" with a target price of $28.00/share. More >

Streetwise Live! Presents Heliostar Metals
Source: Streetwise Reports��(9/14/21)
Streetwise Live! Presents Heliostar Metals Ltd. Featuring Charles Funk, CEO and Director of Heliostar Metals Ltd., Adrian Day of Adrian Day Asset Management, and Joe Mazumdar, Editor/Analyst and Publisher of Exploration Insights. More >

FuelCell Energy Shares Charge Higher After Posting 43% Growth in Q3 Revenue
Source: Streetwise Reports��(9/14/21)
Shares of FuelCell Energy Inc. traded 15% higher after the company reported Q3/21 financial results highlighting positive YoY increases in revenue and gross margins driven by a 102% increase in revenues derived from licenses and service agreements. More >

Company Will Direct Additional Exploration of Two Cornerstone Assets
Source: Streetwise Reports��(9/13/21)
Streetwise Reports spoke to Riley Gold Corp. CEO Todd Hilditch about how they will put “funds in the ground” following an oversubscribed private round. More >

Streetwise Live! Presents E2Gold
Source: Streetwise Reports��(9/13/21)
Streetwise Live! Presents E2Gold Featuring Eric Owens, President, CEO and Director of E2Gold and Dr. Quinton Hennigh, Geologic and Technical Director, Crescat Capital. More >

10 Reasons This Norwegian Industrial Investment Firm Is a Buy, Per Analyst
Source: Streetwise Reports��(9/13/21)
"Aker's discounted pricing and stellar track record stand out as an attractive opportunity in the current market," a Pareto Securities report noted.
More >

Target Price Raised 24% on Top Picks in Oil E&P Space
Source: Streetwise Reports��(9/13/21)
"We think the still out of favor [oil] exploration and production sector offers a good risk/reward," a Pareto Securities report noted. More >

aTyr Pharma's Fusion Protein Achieves Consistent Dose Response in Pulmonary Sarcoidosis Trial
Source: Streetwise Reports��(9/13/21)
Shares of aTyr Pharma Inc. traded 48% higher after the firm reported its ATYR1923 produced positive results in a Phase 1b/2a clinical study by demonstrating consistent favorable dose responses in pulmonary sarcoidosis patients. More >

Echo Global Receives $1.3 Billion Buyout Offer From NY Private Equity Firm
Source: Streetwise Reports��(9/11/21)
Echo Global Logistics Inc. shares traded 50% higher to a new 52-week high after the technology-enabled logistics company reported it entered into a definitive agreement to be acquired by The Jordan Company for $48.25 per share in cash. More >

Alberta Junior Looks to Ride Higher With Steveville Helium Property
Source: Streetwise Reports��(9/10/21)
About 200 km east of Calgary in Canada’s prairies, a small exploration and production company has a plan to become a vertically integrated helium producer. It has the money, a proven helium-producing asset, and signed agreements with partners. Now it’s all about execution — and it’s off to a solid start. More >

Explorer's Infill Drill Results Show Potential for Increasing Resource by 300% at Iberia Belt Property
Source: Streetwise Reports��(9/10/21)
Clarus Securities Inc. advised in a research report that Emerita Resources Corp.'s recent infill drill results at its La Infanta Project in southern Spain demonstrate significant expansion potential. Clarus stated it is maintaining Emerita's "Speculative Buy" rating and 12-month price target of CA$4.50/share. More >

Maiden Drill Results 'Rekindling the Fervor' at Explorer's Utah Gold Project
Source: Streetwise Reports��(9/9/21)
A Haywood Securities report noted that "initial 2021 reverse circulation results highlight deep value in Liberty Gold's asset portfolio." More >

Gevo and Chevron Partner to Invest in Manufacture of Sustainable Aviation Fuel
Source: Streetwise Reports��(9/9/21)
Shares of renewable fuels technology and development company Gevo Inc. traded 35% higher after the company reported it is teaming up with Chevron U.S.A. Inc. to invest in development and production of sustainable aviation fuel derived from inedible corn. More >

Explorer Generates $600K From First Tranche of Private Placement
Source: Streetwise Reports��(9/8/21)
Cortus Metals plans to use the funds to continue exploring its Nevada properties. More >

Gold Explorer's Grab Sampling Extends Mineralized Corridor at Quebec Project From 60 Meters to 4.2 Kilometers
Source: Streetwise Reports��(9/8/21)
"At Quebec Precious Metals' Lloyd discovery area, results received from a 2021 summer surface sampling program highlight several gold discoveries" that show "excellent gold potential." More >

Explorer Estimates 1.1 Billion Cubic Feet of Helium From Second Well Drilled at Alberta Property
Source: Streetwise Reports��(9/8/21)
Auctus Advisors LLP commented in a research note that helium developer Imperial Helium Corp. obtained encouraging results from the second well drilled at its Steveville project. Auctus advised that pending receipt of the well flow rate data, it is maintaining its CA$1.00/share target price for IHC shares. More >

Atlas Salt: Simple, Environmentally Friendly & Huge Potential Cash Flow
Source: Ron Struthers for Streetwise Reports��(9/8/21)
Atlas Salt has a unique project on the west coast of Newfoundland. I would venture to say it is the best risk/reward scenario in the province. Strategically located, the Great Atlantic Salt Project can serve significant North American demand and is uniquely positioned to capture market share from overseas countries with higher shipping costs. More >

Sanofi Makes US$1.9 Billion Offer to Buy Kadmon Holdings to Solidify Its Transplant Business
Source: Streetwise Reports��(9/8/21)
Shares of Kadmon Holdings Inc. traded 70% higher after the firm reported it agreed to be acquired by Sanofi SA for $9.50 per share in cash. Sanofi aims to strengthen its transplant business with the addition of Kadmon's Rezurock™ (belumosudil), an FDA-approved, first-in-class treatment for patients 12 years and older with chronic graft-versus-host disease. More >

VOX Royalty: Massive Portfolio Consisting of 8,000 Royalties
Source: Maurice Jackson for Streetwise Reports��(9/8/21)
In this interview, Maurice Jackson, founder of Proven and Probable, sits down with Kyle Floyd, the CEO of Vox Royalty, which is a global royalty generator with a royalty portfolio consisting of over 8,000 royalties. Jackson and Floyd address the merits of royalty companies for shareholders and what makes Vox Royalty stand out from the pack. More >

Midland, Vista, Lara All Make Progress on Projects, Are 'Best Buys'
Source: Adrian Day for Streetwise Reports��(9/8/21)
The Global Analyst has been focusing on the senior producers more in the last many months, since they are undervalued and more certain to respond to a higher gold price. They remain good buys. However, many of the juniors have seen their stock prices slide and there are excellent buys in that sector. Below are three of our favorite resource juniors, all buys. More >